The full report suite on the global market for gynecological devices includes assisted reproduction technology devices, endometrial ablation devices, endometrial resection devices, mechanical uterine tissue removal devices, uterine fibroid embolization devices, hysteroscopes, colposcopes, pelvic organ prolapse repair devices, fluid management equipment and hysterosalpingography (HSG) catheter devices.
In 2020, the European gynecological devices market size was valued at €157.2 million, with over 6,700 hysteroscopes sold every year. In spite of COVID19, The market size is expected to increase at a compound annual growth rate (CAGR) of 1% to reach €286 million in 2026. Throughout this medical market research, we analyzed 54 gynecology
In 2020, the U.S. gynecological devices market size was valued at approximately $1.2 billion, with over 3.3 million gynecological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 4.4% to exceed $1.5 billion in 2026. Throughout this medical market research, we analyzed 59 Gynecological Device
The global pelvic organ prolapse repair device market size is estimated to increase over the forecast period to reach $180.1 million by 2027. The majority of the global pelvic organ prolapse repair devicemarket share was controlled by Boston Scientific, Coloplast, and Caldera Medical. This global market research spans over 70 countries and includes the transvaginal mesh market and the sacrocolpopexy mesh market.
The global colposcope and hysteroscope market sizes are estimated to increase over the forecast period to reach $143.1 million and $99.5 million, respectively, by 2027. The majority of the global colposcope market share was controlled by Cooper Surgical, Olympus, and Carl Zeiss. For the hysteroscope market, the market share was controlled by Karl Storz, Olympus, and Richard Wolf. This global market research spans over 70 countries and includes the units sold, growth rates, average selling prices, and market values.
The global uterine fibroid embolization (UFE) device market size is estimated to increase over the forecast period to reach $92 million by 2027. The majority of the global uterine fibroid embolization device market share was controlled by Merit Medical Systems and Boston Scientific. This global market research spans over 70 countries and includes microsphere procedures and PVA particle procedures.
Female urinary incontinence affects approximately 10% of the population at some point in their lives. Urinary incontinence affects both women and men; however, there is a greater prevalence of incontinence amongst women. The difference is often attributed to changes that occur during pregnancy and childbirth as well as additional factors such as menopause. There are four main categories recognized for urinary incontinence, with 50% of cases diagnosed as stress urinary incontinence (SUI). Surgical treatment using a urinary incontinence sling is one of the most recommended options to help SUI patients become incontinence-free.
Industry Trends The majority of these U.S. female and neonatal diagnostic devices market segments will see stable growth throughout the forecast period of this report. The largest segment of this market was represented by breast imaging. This is primarily due to the large number of screening procedures performed with these devices, which add to the